title: [Adjunctive pharmacotherapy for acute respiratory distress syndrome].
abstract: Acute respiratory distress syndrome (ARDS) is still regarded as an enormous medical challenge due to its complexity and poor prognosis. In spite of progress in research and therapy lethality remains unacceptably high. Besides established interventiotnal treatment options, numerous pharmacological approaches have been investigated in the past decades.
authors.forename: Matthias
authors.initials: M
authors.lastname: Hecker
authors.forename: Markus A
authors.initials: MA
authors.lastname: Weigand
authors.forename: Konstantin
authors.initials: K
authors.lastname: Mayer
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D000975:Antioxidants / Q000008:administration & dosage*; D017024:Chemotherapy, Adjuvant / Q000401:mortality / Q000706:statistics & numerical data; D019317:Evidence-Based Medicine; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D009125:Muscle Relaxants, Central / Q000008:administration & dosage*; D015995:Prevalence; D012128:Respiratory Distress Syndrome / Q000188:drug therapy* / Q000401:mortality / Q000517:prevention & control; D012307:Risk Factors; D013501:Surface-Active Agents / Q000008:administration & dosage*; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D000975:Antioxidants; D005938:Glucocorticoids; D009125:Muscle Relaxants, Central; D013501:Surface-Active Agents